Latest Commercialization News

N1 Holdings Limited reports robust growth in revenue, EBITDA, and profitability for the December 2024 quarter, underpinned by disciplined risk management and a refined funding strategy.

Omega Oil and Gas Limited has successfully completed drilling and testing of its Canyon-1H horizontal well, revealing encouraging reservoir conditions that set the stage for upcoming fracture stimulation and flowback testing.

Foresta Group Holdings has raised $3.1 million through a convertible note and share placement, while securing exclusive technology licensing and key offtake agreements to propel its flagship New Zealand biomass project.

Singular Health has secured a pivotal MoU with Miami-based Provider Network Solutions and raised $3.7 million to propel its 3Dicom software towards a US commercial pilot, supported by the appointment of esteemed radiologist Dr. Ronny Low.

Enova Mining Limited has completed a $1.5 million placement to fund key developments at its CODA and Charley Creek projects, with the second tranche awaiting shareholder approval.

Enova Mining has completed a $1.5 million placement to fund key development and exploration activities across its CODA, Charley Creek, and Lithium Valley projects. The capital injection aims to accelerate metallurgical testing and engineering work critical to unlocking the value of these rare earth and critical mineral assets.

TrivarX has secured positive feedback from the FDA on its pivotal trial design for MEB-001, an AI-driven algorithm targeting major depressive episode screening via sleep study data. The company is advancing site collaborations to launch a large-scale US trial.

Enova Mining has secured $1.5 million through a two-tranche placement to fund key project developments and exploration activities across its lithium and rare earth assets in Brazil and Australia.

Anatara Lifesciences has been granted a key Australian patent for its GaRP gastrointestinal health product, reinforcing its intellectual property portfolio ahead of pivotal clinical trial results expected in March 2025.

AnteoTech has marked a pivotal quarter with its first commercial Ultranode™ order shipped to Mercedes-Benz and a $4.3 million capital raise to accelerate growth in clean energy and life sciences.

OncoSil Medical has achieved a key regulatory milestone with MDR certification from BSI, removing post-market restrictions and streamlining its commercial operations across Europe. This approval also paves the way for renewed efforts to enter the Australian market.

PARKD Ltd reports substantial structural completions on flagship projects and positive operating cash flow in Q2 FY25, setting the stage for licensing negotiations with Fielders.